Funding for this research was provided by:
National Cancer Institute (R21 CA218309)
Received: 17 December 2018
Accepted: 9 July 2019
First Online: 25 July 2019
Ethics approval and consent to participate
: Ethics approval of this protocol (2015-0013 version 16) was granted by the MD Anderson Cancer Center Institutional Review Board. The trial is conducted in compliance with the Declaration of Helsinki. Informed written consent will be obtained from all participants.
: Not applicable
: The authors declare that they have no competing interests.